Fraisinib: a calixpyrrole derivative reducing A549 cell-derived NSCLC tumor in vivo acts as a ligand of the glycine-tRNA synthase, a new molecular target in oncology by Iméne Ben Toumia, Tiziana Bachetti, Leila Chekir-Ghedira, Aldo Profumo, Marco Ponassi, Alessandro Di Domizio, Alberto Izzotti, Alberto Izzotti, Salvatore Sciacca, Caterina Puglisi, Stefano Forte, Raffaella Giuffrida, Cristina Colarossi, Danilo Milardi, Giuseppe Grasso, Valeria Lanza, Stefano Fiordoro, Giacomo Drago, Kateryna Tkachenko, Barbara Cardinali, Paolo Romano, Erika Iervasi, Gabriela Coronel Vargas, Paola Barboro, Franz Heinrich Kohnke, Camillo Rosano

Connect to this object online.